_id
69105e1cccc777a4e85d5903
Ticker
DVHGF
Name
Devonian Health Group Inc.
Exchange
OTCQB
Address
360, rue des Entrepreneurs, Québec, QC, Canada, G5V 4T1
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://groupedevonian.com
Description
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis associated to radiotherapy, as well as in phase 2a clinical trial for ulcerative colitis. The company also develops Pantoprazole Magnesium for the treatment of gastric reflux; Cleo-35 for the treatment of hormonal acne in women; R-Spinasome anti-aging cream, serum, and regenerating creams; and anti-aging products, including day, night, and eye creams under the Purgenesis name. Devonian Health Group Inc. is headquartered in Québec, Canada.
Last Close
0.0711
Volume
10000
Current Price
0.0711
Change
0
Last Updated
2026-01-02T12:56:05.982Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
22862534
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-10-31
Revenue
1052243
Cost Of Revenue
522131
Gross Profit
530112
Operating Expenses
2646051
Operating Income
-1593808
Interest Expense
1860
Pretax Income
-1559128
Net Income
-1559128
Eps
-0.00939553454792496
Dividends Per Share
-
Shares Outstanding
165943512
Income Tax Expense
-
EBITDA
-
Operating Margin
-151.46767429196487
Total Other Income Expense Net
-
Cash
6642808
Short Term Investments
-
Receivables
1202037
Inventories
30423
Total Current Assets
8502705
Property Plant Equipment
2165746
Total Assets
15570555
Payables
3518418
Short Term Debt
-
Long Term Debt
-
Total Liabilities
5970484
Equity
9600071
Bs_currency_symbol
CAD
Depreciation
38164
Change In Working Capital
-829798
Cash From Operations
-2348902
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2008090
Net Change In Cash
-340812
Cf_currency_symbol
CAD
PE
-
PB
1.2290100461965332
ROE
-16.240796552442163
ROA
-10.013310379752038
FCF
-2348902
Fcf Percent
-2.2322809465114046
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
4.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
6
Quarters > 0 > quarter
2025-10-31
Quarters > 0 > income Statement > revenue
1052243
Quarters > 0 > income Statement > cost Of Revenue
522131
Quarters > 0 > income Statement > gross Profit
530112
Quarters > 0 > income Statement > operating Expenses
2646051
Quarters > 0 > income Statement > operating Income
-1593808
Quarters > 0 > income Statement > interest Expense
1860
Quarters > 0 > income Statement > pretax Income
-1559128
Quarters > 0 > income Statement > net Income
-1559128
Quarters > 0 > income Statement > eps
-0.00939553454792496
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
165943512
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-151.46767429196487
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
6642808
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1202037
Quarters > 0 > balance Sheet > inventories
30423
Quarters > 0 > balance Sheet > total Current Assets
8502705
Quarters > 0 > balance Sheet > property Plant Equipment
2165746
Quarters > 0 > balance Sheet > total Assets
15570555
Quarters > 0 > balance Sheet > payables
3518418
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5970484
Quarters > 0 > balance Sheet > equity
9600071
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-1559128
Quarters > 0 > cash Flow > depreciation
38164
Quarters > 0 > cash Flow > change In Working Capital
-829798
Quarters > 0 > cash Flow > cash From Operations
-2348902
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2008090
Quarters > 0 > cash Flow > net Change In Cash
-340812
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.00939553454792496
Quarters > 0 > ratios > PB
1.2290100461965332
Quarters > 0 > ratios > ROE
-16.240796552442163
Quarters > 0 > ratios > ROA
-10.013310379752038
Quarters > 0 > ratios > FCF
-2348902
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-2.2322809465114046
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-07-31
Quarters > 1 > income Statement > revenue
1278554
Quarters > 1 > income Statement > cost Of Revenue
5116
Quarters > 1 > income Statement > gross Profit
1273438
Quarters > 1 > income Statement > operating Expenses
1692847
Quarters > 1 > income Statement > operating Income
-414293
Quarters > 1 > income Statement > interest Expense
2023
Quarters > 1 > income Statement > pretax Income
-387648
Quarters > 1 > income Statement > net Income
-374964
Quarters > 1 > income Statement > eps
-0.002529736841899314
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
148222532
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-32.40324616715446
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
6983620
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
475884
Quarters > 1 > balance Sheet > inventories
34513
Quarters > 1 > balance Sheet > total Current Assets
8724290
Quarters > 1 > balance Sheet > property Plant Equipment
2203143
Quarters > 1 > balance Sheet > total Assets
15830303
Quarters > 1 > balance Sheet > payables
4356518
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6692635
Quarters > 1 > balance Sheet > equity
9137668
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-374964
Quarters > 1 > cash Flow > depreciation
78167
Quarters > 1 > cash Flow > change In Working Capital
-3135429
Quarters > 1 > cash Flow > cash From Operations
-3356108
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
579423
Quarters > 1 > cash Flow > net Change In Cash
-2776685
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.002529736841899314
Quarters > 1 > ratios > PB
1.153316363124596
Quarters > 1 > ratios > ROE
-4.1034977414368745
Quarters > 1 > ratios > ROA
-2.3686470183167057
Quarters > 1 > ratios > FCF
-3356108
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-2.624924719644223
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-04-30
Quarters > 2 > income Statement > revenue
7363371
Quarters > 2 > income Statement > cost Of Revenue
4667425
Quarters > 2 > income Statement > gross Profit
2695946
Quarters > 2 > income Statement > operating Expenses
7393583
Quarters > 2 > income Statement > operating Income
-30212
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-4803402
Quarters > 2 > income Statement > net Income
-4803402
Quarters > 2 > income Statement > eps
-0.0324066923914105
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
148222532
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-0.41030120579283585
Quarters > 2 > income Statement > total Other Income Expense Net
-4839067
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
9760305
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4949775
Quarters > 2 > balance Sheet > inventories
48008
Quarters > 2 > balance Sheet > total Current Assets
15772602
Quarters > 2 > balance Sheet > property Plant Equipment
2280544
Quarters > 2 > balance Sheet > total Assets
22956782
Quarters > 2 > balance Sheet > payables
4738775
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
14123790
Quarters > 2 > balance Sheet > equity
8832992
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-4803402
Quarters > 2 > cash Flow > depreciation
89018
Quarters > 2 > cash Flow > change In Working Capital
786071
Quarters > 2 > cash Flow > cash From Operations
1347808
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-11258
Quarters > 2 > cash Flow > net Change In Cash
1336550
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.0324066923914105
Quarters > 2 > ratios > PB
1.19309765311686
Quarters > 2 > ratios > ROE
-54.380237183504754
Quarters > 2 > ratios > ROA
-20.923673013055573
Quarters > 2 > ratios > FCF
1347808
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.18304225062135263
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2025-01-31
Quarters > 3 > income Statement > revenue
8827629
Quarters > 3 > income Statement > cost Of Revenue
6214669
Quarters > 3 > income Statement > gross Profit
2612960
Quarters > 3 > income Statement > operating Expenses
8584959
Quarters > 3 > income Statement > operating Income
242670
Quarters > 3 > income Statement > interest Expense
33375
Quarters > 3 > income Statement > pretax Income
209295
Quarters > 3 > income Statement > net Income
-227759
Quarters > 3 > income Statement > eps
-0.001536601736097721
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
148222532
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
2.7489827676265053
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
8423755
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
6914628
Quarters > 3 > balance Sheet > inventories
104021
Quarters > 3 > balance Sheet > total Current Assets
16528416
Quarters > 3 > balance Sheet > property Plant Equipment
2357947
Quarters > 3 > balance Sheet > total Assets
28640681
Quarters > 3 > balance Sheet > payables
5205220
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
15004287
Quarters > 3 > balance Sheet > equity
13636394
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-227759
Quarters > 3 > cash Flow > depreciation
89579
Quarters > 3 > cash Flow > change In Working Capital
-1985208
Quarters > 3 > cash Flow > cash From Operations
-1862754
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-2168486
Quarters > 3 > cash Flow > net Change In Cash
-4031240
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.001536601736097721
Quarters > 3 > ratios > PB
0.7728305610119508
Quarters > 3 > ratios > ROE
-1.6702289476235432
Quarters > 3 > ratios > ROA
-0.7952289961261745
Quarters > 3 > ratios > FCF
-1862754
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.21101407863878285
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2025-07-31
Annuals > 0 > income Statement > revenue
23590335
Annuals > 0 > income Statement > cost Of Revenue
15031784
Annuals > 0 > income Statement > gross Profit
8558551
Annuals > 0 > income Statement > operating Expenses
24361318
Annuals > 0 > income Statement > operating Income
-770983
Annuals > 0 > income Statement > interest Expense
138363
Annuals > 0 > income Statement > pretax Income
-5588421
Annuals > 0 > income Statement > net Income
-6012791
Annuals > 0 > income Statement > eps
-0.0405659714408333
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
148222532
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-3.2682155637043726
Annuals > 0 > income Statement > total Other Income Expense Net
-4839067
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
6983620
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
475884
Annuals > 0 > balance Sheet > inventories
34513
Annuals > 0 > balance Sheet > total Current Assets
8724290
Annuals > 0 > balance Sheet > property Plant Equipment
2203143
Annuals > 0 > balance Sheet > total Assets
15830303
Annuals > 0 > balance Sheet > payables
4356518
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6692635
Annuals > 0 > balance Sheet > equity
9137668
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-6012791
Annuals > 0 > cash Flow > depreciation
345909
Annuals > 0 > cash Flow > change In Working Capital
-1628350
Annuals > 0 > cash Flow > cash From Operations
-1247777
Annuals > 0 > cash Flow > capital Expenditures
17350
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-1613764
Annuals > 0 > cash Flow > net Change In Cash
-2878891
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.0405659714408333
Annuals > 0 > ratios > PB
1.153316363124596
Annuals > 0 > ratios > ROE
-65.80224845113655
Annuals > 0 > ratios > ROA
-37.982791611758785
Annuals > 0 > ratios > FCF
-1265127
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.05362903918066445
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2024-07-31
Annuals > 1 > income Statement > revenue
17815509
Annuals > 1 > income Statement > cost Of Revenue
11826082
Annuals > 1 > income Statement > gross Profit
5989427
Annuals > 1 > income Statement > operating Expenses
5989427
Annuals > 1 > income Statement > operating Income
-858442
Annuals > 1 > income Statement > interest Expense
379831
Annuals > 1 > income Statement > pretax Income
-1224636
Annuals > 1 > income Statement > net Income
-1224636
Annuals > 1 > income Statement > eps
-0.008262144651529768
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
148222532
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-171975
Annuals > 1 > income Statement > operating Margin
-4.818509535708467
Annuals > 1 > income Statement > total Other Income Expense Net
-1224636
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
9862511
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
8280185
Annuals > 1 > balance Sheet > inventories
60889
Annuals > 1 > balance Sheet > total Current Assets
18459810
Annuals > 1 > balance Sheet > property Plant Equipment
2496091
Annuals > 1 > balance Sheet > total Assets
30733450
Annuals > 1 > balance Sheet > payables
3716003
Annuals > 1 > balance Sheet > short Term Debt
2120299
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
16271266
Annuals > 1 > balance Sheet > equity
14462184
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-1224636
Annuals > 1 > cash Flow > depreciation
672830
Annuals > 1 > cash Flow > change In Working Capital
5454181
Annuals > 1 > cash Flow > cash From Operations
5633834
Annuals > 1 > cash Flow > capital Expenditures
4247
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-830012
Annuals > 1 > cash Flow > net Change In Cash
4799575
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.008262144651529768
Annuals > 1 > ratios > PB
0.7287019737267898
Annuals > 1 > ratios > ROE
-8.467849669178596
Annuals > 1 > ratios > ROA
-3.9847007088367885
Annuals > 1 > ratios > FCF
5629587
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.31599360983736136
Annuals > 1 > health Score
43
Annuals > 2 > quarter
2023-07-31
Annuals > 2 > income Statement > revenue
2345389
Annuals > 2 > income Statement > cost Of Revenue
1453048
Annuals > 2 > income Statement > gross Profit
892341
Annuals > 2 > income Statement > operating Expenses
892341
Annuals > 2 > income Statement > operating Income
-4283427
Annuals > 2 > income Statement > interest Expense
459674
Annuals > 2 > income Statement > pretax Income
-4599607
Annuals > 2 > income Statement > net Income
-4599607
Annuals > 2 > income Statement > eps
-0.033928798979068975
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
135566455
Annuals > 2 > income Statement > income Tax Expense
255556
Annuals > 2 > income Statement > EBITDA
-3716482
Annuals > 2 > income Statement > operating Margin
-182.63183633930237
Annuals > 2 > income Statement > total Other Income Expense Net
-316180
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
5062936
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
940768
Annuals > 2 > balance Sheet > inventories
159783
Annuals > 2 > balance Sheet > total Current Assets
6344978
Annuals > 2 > balance Sheet > property Plant Equipment
2684022
Annuals > 2 > balance Sheet > total Assets
19177478
Annuals > 2 > balance Sheet > payables
753601
Annuals > 2 > balance Sheet > short Term Debt
3601646
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4930026
Annuals > 2 > balance Sheet > equity
14247452
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-4599607
Annuals > 2 > cash Flow > depreciation
423451
Annuals > 2 > cash Flow > change In Working Capital
-316256
Annuals > 2 > cash Flow > cash From Operations
-4356246
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1613991
Annuals > 2 > cash Flow > net Change In Cash
2257745
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.033928798979068975
Annuals > 2 > ratios > PB
0.676526227321208
Annuals > 2 > ratios > ROE
-32.283716414696464
Annuals > 2 > ratios > ROA
-23.984420683470475
Annuals > 2 > ratios > FCF
-4356246
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.8573660915097665
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2022-07-31
Annuals > 3 > income Statement > revenue
2305188
Annuals > 3 > income Statement > cost Of Revenue
1744173
Annuals > 3 > income Statement > gross Profit
561015
Annuals > 3 > income Statement > operating Expenses
3473581
Annuals > 3 > income Statement > operating Income
-2872914
Annuals > 3 > income Statement > interest Expense
936971
Annuals > 3 > income Statement > pretax Income
-3448302
Annuals > 3 > income Statement > net Income
-3448302
Annuals > 3 > income Statement > eps
-0.02897052233629085
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
119027954
Annuals > 3 > income Statement > income Tax Expense
936971
Annuals > 3 > income Statement > EBITDA
-2009045
Annuals > 3 > income Statement > operating Margin
-124.62818650799848
Annuals > 3 > income Statement > total Other Income Expense Net
-575388
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2805191
Annuals > 3 > balance Sheet > short Term Investments
5000000
Annuals > 3 > balance Sheet > receivables
219952
Annuals > 3 > balance Sheet > inventories
154622
Annuals > 3 > balance Sheet > total Current Assets
8417229
Annuals > 3 > balance Sheet > property Plant Equipment
2884656
Annuals > 3 > balance Sheet > total Assets
21586071
Annuals > 3 > balance Sheet > payables
410443
Annuals > 3 > balance Sheet > short Term Debt
12060
Annuals > 3 > balance Sheet > long Term Debt
4256588
Annuals > 3 > balance Sheet > total Liabilities
5313542
Annuals > 3 > balance Sheet > equity
16272529
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3448302
Annuals > 3 > cash Flow > depreciation
863869
Annuals > 3 > cash Flow > change In Working Capital
-602375
Annuals > 3 > cash Flow > cash From Operations
-2871582
Annuals > 3 > cash Flow > capital Expenditures
79444
Annuals > 3 > cash Flow > cash From Investing
-5079444
Annuals > 3 > cash Flow > cash From Financing
10411422
Annuals > 3 > cash Flow > net Change In Cash
2460396
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.02897052233629085
Annuals > 3 > ratios > PB
0.5200720508410217
Annuals > 3 > ratios > ROE
-21.19094087956457
Annuals > 3 > ratios > ROA
-15.97466254975257
Annuals > 3 > ratios > FCF
-2951026
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.280167170747028
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.00939553454792496
Valuation > metrics > PB
1.2290100461965332
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-16.240796552442163
Profitability > metrics > ROA
-18.33684692106806
Profitability > metrics > Net Margin
-1.4817185764124827
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6219208170439573
Risk > metrics > Interest Coverage
-856.8860215053763
Risk > final Score
-3380
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.4166273023841964
Liquidity > metrics > Quick Ratio
2.407980518517129
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-771
Prev Risks > 1
30
Prev Risks > 2
59
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:44:31.364Z
Earnings History > 0 > period
2026-01-31
Earnings History > 0 > report Date
2026-04-15
Earnings History > 0 > date
2026-01-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-10-31
Earnings History > 1 > report Date
2025-12-23
Earnings History > 1 > date
2025-10-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0068
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-07-31
Earnings History > 2 > report Date
2025-07-31
Earnings History > 2 > date
2025-07-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0018
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-04-30
Earnings History > 3 > report Date
2025-04-30
Earnings History > 3 > date
2025-04-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0228
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2025-01-31
Earnings History > 4 > report Date
2025-03-25
Earnings History > 4 > date
2025-01-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.0011
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-10-31
Earnings History > 5 > report Date
2024-12-20
Earnings History > 5 > date
2024-10-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0018
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-07-31
Earnings History > 6 > report Date
2024-07-31
Earnings History > 6 > date
2024-07-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
0.0053
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-04-30
Earnings History > 7 > report Date
2024-06-25
Earnings History > 7 > date
2024-04-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.0019
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-01-31
Earnings History > 8 > report Date
2024-03-27
Earnings History > 8 > date
2024-01-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0061
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-10-31
Earnings History > 9 > report Date
2023-12-22
Earnings History > 9 > date
2023-10-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0036
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-07-31
Earnings History > 10 > report Date
2023-07-31
Earnings History > 10 > date
2023-07-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.0045
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-04-30
Earnings History > 11 > report Date
2023-06-30
Earnings History > 11 > date
2023-04-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.008
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-01-31
Earnings History > 12 > report Date
2023-01-31
Earnings History > 12 > date
2023-01-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.0057
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-10-31
Earnings History > 13 > report Date
2022-12-22
Earnings History > 13 > date
2022-10-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.0069
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis associated to radiotherapy, as well as in phase 2a clinical trial for ulcerative colitis. The company also develops Pantoprazole Magnesium for the treatment of gastric reflux; Cleo-35 for the treatment of hormonal acne in women; R-Spinasome anti-aging cream, serum, and regenerating creams; and anti-aging products, including day, night, and eye creams under the Purgenesis name. Devonian Health Group Inc. is headquartered in Québec, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADevonian Health share count drops from 165,943,512 to approx. 2,765,725 Stock Titan
Read more →Devonian Health Group Announces Grant of Stock Options Yahoo! Finance Canada
Read more →Showing 2 of 4
(Last Updated 2025-10-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Devonian Health Group Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-01-31
EPS Estimate
—
Date
2025-10-31
EPS Actual
-0.0068
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-10-31)
(Last Updated 2025-10-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-10-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-10-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.